Evommune (EVMN) Earnings Analysis
Evommune (EVMN) next reports earnings on 2026-10-16, consensus EPS -0.82 USD. Last quarter (2026-05-07) it beat with EPS -0.64 USD vs -0.83 USD est (+22.9%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -4.77.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EVMN next report earnings?
| Next earnings date | 2026-10-16 |
|---|---|
| Consensus EPS estimate | -0.82 USD |
| Revenue estimate | 0.00B |
EVMN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -0.64 USD | -0.83 USD | +22.9% | Beat |
| 2026-03-05 | -1.43 USD | -0.82 USD | -74.4% | Miss |
| 2025-12-11 | -8.07 USD | -6.08075 USD | -32.7% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
EVMN valuation and analyst view
| Trailing P/E | -4.77 |
|---|---|
| Trailing EPS | -2.25681 USD |
| Price / book | 1.26 |
| Dividend yield | 0.00% |
| Market cap | 0.16B |
| Analyst consensus | Buy (2 buy / 2 hold / 0 sell) |
| Avg price target | 43.67 USD |
Related research pages
Frequently asked questions
When is Evommune (EVMN)'s next earnings date?
Evommune is next scheduled to report on 2026-10-16, with a consensus EPS estimate of -0.82 USD and revenue estimate of 0.00B.
Did EVMN beat earnings last quarter?
In its 2026-05-07 report, EVMN posted EPS of -0.64 USD versus a -0.83 USD estimate — a beat of 22.9%.
What is EVMN's earnings track record?
Over the last 3 reported quarters with consensus data, EVMN beat estimates 1 times (33%).
What is EVMN's current P/E ratio and EPS?
EVMN trades at a trailing P/E of -4.77 on trailing EPS of -2.2568062367887425 USD.
What do analysts rate EVMN?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 43.67 USD.